Difficulty: Medium
Average Score: 86%
Practice
Management of thalassaemia includes:
Correct answer
C
Rationale
In the management of thalassaemia, the correct option is C) Bone marrow transplant. Thalassaemia is a genetic blood disorder characterized by abnormal hemoglobin production. A bone marrow transplant offers a potential cure by replacing the faulty bone marrow with healthy stem cells that can produce normal hemoglobin.
A) Whole blood transfusions are used to provide symptomatic relief by replenishing red blood cells, but they do not cure thalassaemia.
B) Pneumovax is a vaccine used to prevent pneumococcal infections, which are not directly related to the management of thalassaemia.
D) Penicillin V prophylaxis may be prescribed to prevent infections in individuals with thalassaemia, but it is not a curative treatment.
Educationally, understanding the management of thalassaemia is crucial for pediatric nurses caring for children with this condition. Knowing the appropriate interventions, such as bone marrow transplant, can help nurses provide comprehensive and effective care to improve outcomes for their patients. It is essential for nurses to be knowledgeable about the different treatment options available to provide safe and evidence-based care for children with thalassaemia.
A) Whole blood transfusions are used to provide symptomatic relief by replenishing red blood cells, but they do not cure thalassaemia.
B) Pneumovax is a vaccine used to prevent pneumococcal infections, which are not directly related to the management of thalassaemia.
D) Penicillin V prophylaxis may be prescribed to prevent infections in individuals with thalassaemia, but it is not a curative treatment.
Educationally, understanding the management of thalassaemia is crucial for pediatric nurses caring for children with this condition. Knowing the appropriate interventions, such as bone marrow transplant, can help nurses provide comprehensive and effective care to improve outcomes for their patients. It is essential for nurses to be knowledgeable about the different treatment options available to provide safe and evidence-based care for children with thalassaemia.